Ledger.Open graph →
SEC Form D · Amendment · filed November 2, 2012

Presidio Pharmaceuticals, Inc

Offering
$14.4M
Sold
$14.4M
Exemption
—
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (18)

Kenneth Galbraith · San Francisco, CAExec · DirectorNathaniel Brown · San Francisco, CAExecSrinivas Akkaraju · San Francisco, CADirectorJohn F. Obijeski · San Francisco, CADirectorLeo Redmond · San Francisco, CAExec · DirectorH. Daniel Perez · San Francisco, CAExec · DirectorFelix Baker · San Francisco, CADirectorRodney Ferguson · San Francisco, CADirectorRichard Colonno · San Francisco, CAExecJohn G. Barrie · EDINBURGH, SCOTLAND, United KingdomExec · DirectorGeorge W. Browning · EDINBURGH, SCOTLAND, United KingdomExec · DirectorAlan W. Paterson · EDINBURGH, SCOTLAND, United KingdomDirectorEdward H. Hocknell · EDINBURGH, SCOTLAND, United KingdomDirectorDickson H. Jackson · EDINBURGH, SCOTLAND, United KingdomDirectorRon Hunt · East Providence, RIDirectorJoshua M. Braunfeld · New York, NYExec · DirectorRobert Weiss · New York, NYExecKevin B. Cashen · Lutherville, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗